Comparison between Optimal Coherence tomography guidance and Angiography Guidance in percutaneous coronary intervention - COCOA study

Wakayama Medical University0 个研究点目标入组 550 人开始时间: 2017年2月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with ST elevation myocardial infarction(STEMI) 2) Hemodynamic supplements or vasopressors with cardiogenic shock (defined as persistent hypotension with systolic blood pressure <90mm/Hg persisting for more than 30 minutes) or pressure rising/intra-aortic balloon pumping at the time of the procedure Required patient 3) Heart failure patients 4) Patients with three branches disease 5) Patients planned to use bare metal stent (BMS) 6) Patients with renal dysfunction (eGFR 30ml/min/1.73m2 or less or serum creatinine 1.5mg/dl or more) 7) Patients during dialysis treatment 8) Patients who are known to have allergies to aspirin, clopidogrel, prasugrel, heparin, iodine contrast medium, 9) Patients with hemorrhagic complications such as intracranial hemorrhage and gastrointestinal bleeding 10) Patients planning surgical treatment with in 12month after PCI 11) Patients with one or more co-morbidities that shorten life expectancy to less than 12 months or that may interfere with the study process according to this study protocol 12) Patients participating in clinical trials of other medical devices and drugs and judged by the attending physician as affecting the main endpoint of this study 13) Patients scheduled to use IVUS for the PCI to be tested 14) Patients whose treatment subject lesion morphology falls under any of the following

发起方